Oncolytics Biotech
ONCY
$1.19
Share price
0.85%
Change (1 day)
-30.41%
Change (1 year)
Categories
Oncolytics Biotech (ONCY) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $8.5 M
According to Oncolytics Biotech 's latest financial reports the company's total liabilities are $8.5 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $8.5 M | 6.19% |
| 2022-12-31 | $8 M | 4.33% |
| 2021-12-31 | $7.67 M | 2.01% |
| 2020-12-31 | $7.52 M | -50.29% |
| 2019-12-31 | $15.13 M | 137.78% |
| 2018-12-31 | $6.36 M | -18.85% |
| 2017-12-31 | $7.84 M | 158.95% |
| 2016-12-31 | $3.02 M | 55.06% |
| 2015-12-31 | $1.95 M | -32.82% |
| 2014-12-31 | $2.9 M | -48.49% |
| 2013-12-31 | $5.64 M | -23.02% |
| 2012-12-31 | $7.33 M | 15.09% |
| 2011-12-31 | $6.37 M | 154.67% |
| 2010-12-31 | $2.5 M | -37.73% |
| 2009-12-31 | $4.01 M | 7.73% |
| 2008-12-31 | $3.72 M | 31.86% |
| 2007-12-31 | $2.82 M | 19.02% |
| 2006-12-31 | $2.37 M | 50.24% |
| 2005-12-31 | $1.58 M | 72.81% |
| 2004-12-31 | $0.91 M | 14.71% |
| 2003-12-31 | $0.79 M | -22.57% |
| 2002-12-31 | $1.03 M | -54.78% |
| 2001-12-31 | $2.27 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $51.04 B | 600,246.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 969,970.97% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | $0.18 B | 2,055.10% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $18.82 M | 121.34% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 415,681.66% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | $72.38 M | 751.35% | 🇺🇸 USA |